Screening memory T cell frequency
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology
The Costimulatory Molecule CD27 Maintains Clonally Diverse CD8+ T Cell Responses of Low Antigen Affinity to Protect against Viral Variants - ScienceDirect
B cell sub-types following acute malaria and associations with clinical immunity | Malaria Journal | Full Text
T Cell Markers and B Cell Markers
Role of CD27/CD70 pathway of activation in immunity and tolerance - Denoeud - 2011 - Journal of Leukocyte Biology - Wiley Online Library
The CD70-CD27 axis in oncology: the new kids on the block | Journal of Experimental & Clinical Cancer Research | Full Text
Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
From “truly naïve” to “exhausted senescent” T cells: When markers predict functionality - Larbi - 2014 - Cytometry Part A - Wiley Online Library
B Cell Overview | Thermo Fisher Scientific - US
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology
CD27 Pathway
Frontiers | Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management
Double‐negative (DN) B cells: an under‐recognized effector memory B cell subset in autoimmunity - Li - 2021 - Clinical & Experimental Immunology - Wiley Online Library
CD27 Assay Portfolio Service - Creative Biolabs
Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy
CD27 expression and its association with clinical outcome in children and adults with pro-B acute lymphoblastic leukemia | Blood Cancer Journal
Distinct profiles of activation marker expression on memory CD27 IgG B... | Download Scientific Diagram
CD27: a memory B-cell marker
The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory - ScienceDirect
The role of CD27 in anti-viral T-cell immunity - ScienceDirect
Frontiers | Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation
T cell Activation Marker (CD69, CD137, CD27, TRAP/CD40L, CD134) Antibody Panel - Human (ab254024)
